⌘K

Login Start Free

Home/Filings/4/0001213900-18-010829

4//SEC Filing

Friedman Aviad 4

Accession 0001213900-18-010829

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 4:32 PM ET

Size

6.8 KB

Accession

0001213900-18-010829

Insider Transaction Report

Form 4

Period: 2018-08-09

ORAMED PHARMACEUTICALS INC.ORMP

Director

Transactions

Purchase
Common Stock
2018-08-09$4.82/sh+500$2,410→ 10,191 total(indirect: By wholly-owned corporation)
Purchase
Common Stock
2018-08-09$4.98/sh+2,000$9,960→ 12,191 total(indirect: By wholly-owned corporation)

Holdings

Common Stock
10,000

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001683729

Filing Metadata

Form type: 4
Filed: Aug 12, 8:00 PM ET
Accepted: Aug 13, 4:32 PM ET
Size: 6.8 KB

View on SEC.gov